Abstract
The study characterized COVID-19 transmission in Ghana in 2020-21 by estimating the time-varying reproduction number (Rt) and exploring its association with various public health interventions at the national and regional levels. Ghana experienced four pandemic waves with epidemic peaks in July 2020, and January, August and December, 2021. The epidemic peak was the highest nationwide in December 2021 with Rt ≥2. Throughout 2020-21, per-capita cumulative case count by region increased with population size. Mobility data suggested negative correlation between Rt and staying home in the first 90 days of the pandemic. The relaxation of movement restrictions and religious gatherings were not associated with increased Rt in the regions with lower case burdens. Rt decreased from above 1 when schools reopened in January 2021 to below 1 after vaccination rollout in March 2021. Findings indicated most public health interventions were associated with Rt reduction at the national and regional levels.
Competing Interest Statement
Sylvia Ofori declares that she was a paid intern at Ionis Pharmaceuticals and the financial relationship does not affect the content of the article. Dr. Isaac C. H. Fung declares that he has invested in equity in Alphabet, Inc. (GOOGL). Prof. Benjamin Cowling declares that he was a consultant for Roche and Sanofi Pasteur. All other co-authors declare no competing interest.
Funding Statement
The research reported in this paper is not supported by any external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Georgia Southern University IRB determined a non-human subject status for this project (H20364) under the G8 exemption category as per the Code of Federal Regulations Title 45 Part 46.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We extended the study period to the end of 2021 (date of report). Our results have been updated and some paragraphs have been fully revised. We used data from the Johns Hopkins University COVID-19 dashboard because the website of Ghana Health Service no longer facilitated download of historic data. In our regional analysis, we now focused on regions of Ghana with high case counts and excluded regions with less than 4000 cumulative case count from our Rt analysis. The regions included in the revised version were Greater Accra, Ashanti, Western, Eastern, Central and Volta regions.
Data Availability
All the data analyzed herein are publicly available, aggregate, data. The daily number of new infections and daily cumulative incidence data by date of report for Ghana and each of its regions are available at the Johns Hopkins University COVID-19 dashboard. The mobility data is available through Google Mobility Report.
